A Study to Evaluating the Efficacy and Safety of Recombinant Long-acting Human Growth Hormone (TJ101) in Children With Growth Hormone Deficiency

NCT04633057 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Growth Hormone Deficiency

Interventions

DRUG: TJ101
DRUG: NordiFlex

Sponsor

TJ Biopharma Co., Ltd.